Acceleration of osteoblastic cell differentiation and mineralization by fibroblast growth factor receptor (FGFR) 2 with apert mutation

被引:0
|
作者
Taninoto, Y
Yokozeki, M
Hiura, K
Matsumoto, K
Nakanishi, H
Moriyama, K
机构
[1] Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 770, Japan
[2] Univ Tokushima, Univ Hosp, Plast & Reconstruct Surg Sect, Tokushima 770, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S141 / S141
页数:1
相关论文
共 50 条
  • [41] A Ser252Trp Mutation in Fibroblast Growth Factor Receptor 2 (FGFR2) Mimicking Human Apert Syndrome Reveals an Essential Role for FGF Signaling in the Regulation of Endochondral Bone Formation
    Chen, Peng
    Zhang, Li
    Weng, Tujun
    Zhang, Shichang
    Sun, Shijin
    Chang, Mingtao
    Li, Yang
    Zhang, Bo
    Zhang, Lianyang
    PLOS ONE, 2014, 9 (01):
  • [42] The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation
    Lemonnier, J
    Delannoy, P
    Hott, M
    Lomri, A
    Modrowski, D
    Marie, PJ
    EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) : 158 - 167
  • [43] Fibroblast growth factor receptor (FGFR) 2 Illc, is a novel molecular target for suppressing pancreatic cancer cell growth and migration
    Ishiwata, Toshiyuki
    Matsuda, Yoko
    Kawahara, Kiyoko
    Yamamoto, Tetsushi
    Teduka, Kiyoshi
    Uchida, Eiji
    Korc, Murray
    Naito, Zenya
    CANCER RESEARCH, 2010, 70
  • [44] An unusual FGFR1 mutation (fibroblast growth factor receptor 1 mutation) in a girl with non-syndromic trigonocephaly
    Kress, W
    Petersen, B
    Collmann, H
    Grimm, T
    CYTOGENETICS AND CELL GENETICS, 2000, 91 (1-4): : 138 - 140
  • [45] Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand
    Anderson, J
    Burns, HD
    Enriquez-Harris, P
    Wilkie, AOM
    Heath, JK
    HUMAN MOLECULAR GENETICS, 1998, 7 (09) : 1475 - 1483
  • [46] Fibroblast growth factor receptor (FGFR) inhibitor Treatment of intrahepatic cholangiocarcinoma
    Shaib, W. L.
    El-Rayes, B. F.
    DRUGS OF THE FUTURE, 2017, 42 (11) : 677 - 683
  • [47] Identification of a new fibroblast growth factor receptor, FGFR5
    Sleeman, M
    Fraser, J
    McDonald, M
    Yuan, SN
    White, D
    Grandison, P
    Kumble, K
    Watson, JD
    Murison, JG
    GENE, 2001, 271 (02) : 171 - 182
  • [48] Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma
    Lamarca, Angela
    Ostios, Lorena
    Mcnamara, Mairead G.
    Garzon, Carlos
    Gleeson, Jack P.
    Edeline, Julien
    Herrero, Ana
    Hubner, Richard A.
    Moreno, Victor
    Valle, Juan W.
    CANCER TREATMENT REVIEWS, 2023, 121
  • [49] Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
    Pacini, Laura
    Jenks, Andrew D.
    Lima, Nadia Carvalho
    Huang, Paul H.
    CELLS, 2021, 10 (05)
  • [50] Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers
    Bhateja, Priyanka
    Liu, Xuefeng
    Baliga, Sujith
    Gogineni, Emile
    Jhawar, Sachin
    Mitchell, Darrion
    Ma, Sungjun
    Zhu, Simeng
    Konieczkowski, David
    Blakaj, Dukagjin
    Old, Matthew
    Rocco, James
    Bonomi, Marcelo
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (11)